Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor–based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials

Background. Previous studies suggest that nonnucleoside reverse-transcriptase inhibitors (NNRTIs) cause faster virologic suppression, while ritonavir-boosted protease inhibitors (PI/r) recover more CD4 cells. However, individual trials have not been powered to compare clinical outcomes. Methods. We...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Infect Dis
Egile Nagusiak: Borges, Álvaro H., Lundh, Andreas, Tendal, Britta, Bartlett, John A., Clumeck, Nathan, Costagliola, Dominique, Daar, Eric S., Echeverría, Patrícia, Gisslén, Magnus, Huedo-Medina, Tania B., Hughes, Michael D., Huppler Hullsiek, Katherine, Khabo, Paul, Komati, Stephanus, Kumar, Princy, Lockman, Shahin, MacArthur, Rodger D., Maggiolo, Franco, Matteelli, Alberto, Miro, Jose M., Oka, Shinichi, Petoumenos, Kathy, Puls, Rebekah L., Riddler, Sharon A., Sax, Paul E., Sierra-Madero, Juan, Torti, Carlo, Lundgren, Jens D.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2016
Gaiak:
HIV/AIDS
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6276924/
https://ncbi.nlm.nih.gov/pubmed/27090986
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciw236
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak